356 related articles for article (PubMed ID: 27727005)
1. Clinical inertia to insulin initiation and intensification in the UK: A focused literature review.
Khunti K; Millar-Jones D
Prim Care Diabetes; 2017 Feb; 11(1):3-12. PubMed ID: 27727005
[TBL] [Abstract][Full Text] [Related]
2. Patterns and trends in insulin intensification among patients with type 2 diabetes: a systematic review.
Polinski JM; Connolly JG; Curtis BH; Seeger JD; Gaskins K; Perez M; Smith BF; Shrank WH
Prim Care Diabetes; 2014 Jul; 8(2):101-9. PubMed ID: 24275103
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic inertia amongst general practitioners with interest in diabetes.
Seidu S; Than T; Kar D; Lamba A; Brown P; Zafar A; Hussain R; Amjad A; Capehorn M; Martin E; Fernando K; McMoran J; Millar-Jones D; Kahn S; Campbell N; Brice R; Mohan R; Mistry M; Kanumilli N; St John J; Quigley R; Kenny C; Khunti K
Prim Care Diabetes; 2018 Feb; 12(1):87-91. PubMed ID: 28993141
[TBL] [Abstract][Full Text] [Related]
4. Overcoming clinical inertia in insulin initiation in primary care for patients with type 2 diabetes: 24-month follow-up of the Stepping Up cluster randomised controlled trial.
Manski-Nankervis JA; Furler J; O'Neal D; Ginnivan L; Thuraisingam S; Blackberry I
Prim Care Diabetes; 2017 Oct; 11(5):474-481. PubMed ID: 28705697
[TBL] [Abstract][Full Text] [Related]
5. Perceptions of general practitioners on initiation and intensification of type 2 diabetes injectable therapies. A quantitative study in the United Kingdom.
Sterzi D; Auziere S; Glah D; Markert Jensen M
Prim Care Diabetes; 2017 Jun; 11(3):241-247. PubMed ID: 28395938
[TBL] [Abstract][Full Text] [Related]
6. Results from the UK cohort of SOLVE: providing insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice.
Khunti K; Vora J; Davies M
Prim Care Diabetes; 2014 Apr; 8(1):57-63. PubMed ID: 24378771
[TBL] [Abstract][Full Text] [Related]
7. Challenges of maintaining research protocol fidelity in a clinical care setting: a qualitative study of the experiences and views of patients and staff participating in a randomized controlled trial.
Lawton J; Jenkins N; Darbyshire JL; Holman RR; Farmer AJ; Hallowell N
Trials; 2011 May; 12():108. PubMed ID: 21542916
[TBL] [Abstract][Full Text] [Related]
8. Associated factors that influenced persistence with basal analog insulin therapy among people with type 2 diabetes: An exploratory analysis from a UK real-world sample.
Idris I; Gulati K; Perez-Nieves M; Hadjiyianni I; Cao D; Tahbaz A; Ivanova J; Hassan SW
Prim Care Diabetes; 2019 Apr; 13(2):106-112. PubMed ID: 30477969
[TBL] [Abstract][Full Text] [Related]
9. Gaps and barriers in the control of blood glucose in people with type 2 diabetes.
Blonde L; Aschner P; Bailey C; Ji L; Leiter LA; Matthaei S;
Diab Vasc Dis Res; 2017 May; 14(3):172-183. PubMed ID: 28467203
[TBL] [Abstract][Full Text] [Related]
10. Primary care physician perspectives on basal insulin initiation and maintenance in patients with type 2 diabetes mellitus.
Kalirai S; Stephenson J; Perez-Nieves M; Grabner M; Hadjiyianni I; Geremakis C; Pollom RD; Reed B; Fisher L
Prim Care Diabetes; 2018 Apr; 12(2):155-162. PubMed ID: 29100717
[TBL] [Abstract][Full Text] [Related]
11. Approaches to rapid acting insulin intensification in patients with type 2 diabetes mellitus not achieving glycemic targets.
Migdal A; Abrahamson M; Peters A; Vint N
Ann Med; 2018 Sep; 50(6):453-460. PubMed ID: 30103624
[TBL] [Abstract][Full Text] [Related]
12. Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin.
Khunti K; Nikolajsen A; Thorsted BL; Andersen M; Davies MJ; Paul SK
Diabetes Obes Metab; 2016 Apr; 18(4):401-9. PubMed ID: 26743666
[TBL] [Abstract][Full Text] [Related]
13. Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients.
Ajjan RA; Abougila K; Bellary S; Collier A; Franke B; Jude EB; Rayman G; Robinson A; Singh BM
Diab Vasc Dis Res; 2016 May; 13(3):211-9. PubMed ID: 27000105
[TBL] [Abstract][Full Text] [Related]
14. Insulin initiation in primary care for patients with type 2 diabetes: 3-year follow-up study.
Dale J; Martin S; Gadsby R
Prim Care Diabetes; 2010 Jul; 4(2):85-9. PubMed ID: 20392683
[TBL] [Abstract][Full Text] [Related]
15. Individualised treatment targets in patients with type-2 diabetes and hypertension.
Schmieder RE; Tschöpe D; Koch C; Ouarrak T; Gitt AK;
Cardiovasc Diabetol; 2018 Jan; 17(1):18. PubMed ID: 29357854
[TBL] [Abstract][Full Text] [Related]
16. A Simplified Approach Using Rate of Change Arrows to Adjust Insulin With Real-Time Continuous Glucose Monitoring.
Klonoff DC; Kerr D
J Diabetes Sci Technol; 2017 Nov; 11(6):1063-1069. PubMed ID: 28884599
[No Abstract] [Full Text] [Related]
17. Ethnic disparities in initiation and intensification of diabetes treatment in adults with type 2 diabetes in the UK, 1990-2017: A cohort study.
Mathur R; Farmer RE; Eastwood SV; Chaturvedi N; Douglas I; Smeeth L
PLoS Med; 2020 May; 17(5):e1003106. PubMed ID: 32413037
[TBL] [Abstract][Full Text] [Related]
18. Understanding drug preferences, different perspectives.
Mol PG; Arnardottir AH; Straus SM; de Graeff PA; Haaijer-Ruskamp FM; Quik EH; Krabbe PF; Denig P
Br J Clin Pharmacol; 2015 Jun; 79(6):978-87. PubMed ID: 25469876
[TBL] [Abstract][Full Text] [Related]
19. Patient engagement impacts glycemic management with vildagliptin and vildagliptin/metformin (single pill) regimens in type 2 diabetes mellitus (the GLORIOUS study).
Hermans M; Van Gaal L; Rézette I; Daci E; MacDonald K; Denhaerynck K; Vancayzeele S; De Meester L; Clemens A; Yee B; Abraham I
Prim Care Diabetes; 2016 Dec; 10(6):425-433. PubMed ID: 27388795
[TBL] [Abstract][Full Text] [Related]
20. Makes FLASH the difference between the intervention group and the treatment-as-usual group in an evaluation study of a structured education and treatment programme for flash glucose monitoring devices in people with diabetes on intensive insulin therapy: study protocol for a randomised controlled trial.
Schipfer M; Albrecht C; Ehrmann D; Haak T; Kulzer B; Hermanns N
Trials; 2018 Feb; 19(1):91. PubMed ID: 29402319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
